Goldowsky’s greed, incompetence, lack of business acumen, inept social skills and self-interest have all violated his fiduciary duty to the shareholders and have dealt a fatal blow to the project.
Misleading the shareholders: Goldowsky has been misleading the shareholders from the very beginning, by not disclosing all the adverse effects his unethical conduct has had on the company(s) we all invested in. He has been completely derelict in his duty as a CEO and trustee of more than $1.4M of investor’s money. He has breached […]
Since August 22, 2000 Goldowsky has operated three corporations from three different states. He has raised the bulk of $1.4M under Gold Medical Technologies, Inc., but then he bankrupted this company in 2006 to avoid paying a judgment. Then he supposedly assigned the patent rights to the new corporation and selectively issued new shares of […]
Misrepresentation of Patent Protection Goldowsky induced investors and consultants to infuse money and labor into the MagneVAD project, on the basis of the strong Intellectual Property value owned by him and licensed to the company. There are two U.S. patents owned by Goldowsky relating to the MagneVAD blood pump device. Patent 6,527,699 issued on 03/04/2003 […]